Toggle light / dark theme

Monitoring electrical signals in biological systems helps scientists understand how cells communicate, which can aid in the diagnosis and treatment of conditions like arrhythmia and Alzheimer’s.

But devices that record electrical signals in cell cultures and other liquid environments often use wires to connect each electrode on the device to its respective amplifier. Because only so many wires can be connected to the device, this restricts the number of recording sites, limiting the information that can be collected from cells.

MIT researchers have now developed a biosensing technique that eliminates the need for wires. Instead, tiny, wireless antennas use light to detect minute electrical signals.

A glowing galaxy not far from the Milky Way has been harboring a strange, puzzling secret at its core.

In the center of NGC 5,084, some 80 million light-years away, the supermassive black hole around which the whole galaxy revolves has been discovered tipped over on its side, with its rotational axis parallel to the galactic plane.

It’s a bit like the Uranus of black holes, and astronomers are uncertain how it could have gotten that way – especially since the evidence suggests that it wasn’t always oriented as it is in our current observations.

Leveraging the success of this new program, just about two years from its launch DeepMind’s AI spinout Isomorphic announced two drug discovery deals, worth $3 billion each, with Eli Lilly and Novartis.

Earlier this year, microprocessor giant NVIDIA also dove head first into AI for drug discovery, making big investments and deals with leaders like Recursion Pharmaceuticals and Genentech.

AI in drug discovery seems to be having a moment.